Swedish Orphan Biovitrum AB

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000872095
SEK
343.00
5.2 (1.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1142775,
    "name": "Swedish Orphan Biovitrum AB",
    "stock_name": "Swedish Orphan Biovitrum AB",
    "full_name": "Swedish Orphan Biovitrum AB",
    "name_url": "stocks-analysis/swedish-orphan-biovitrum-ab",
    "exchange": 1025,
    "exchangecode": "OME",
    "country_id": 29,
    "currency": "SEK",
    "cmp": "343.00",
    "chg": 5.2,
    "chgp": "1.54%",
    "dir": 1,
    "prev_price": "337.80",
    "mcapval": "121,305.92",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "OMX Stockholm 30",
    "isin": "SE0000872095",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "992.78 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/swedish-orphan-biovitrum-ab-1142775-1025&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Swedish Orphan Biovitrum AB Reports Significant Profit Growth Amid Financial Reevaluation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/swedish-orphan-biovitrum-ab-receives-stock-upgrade-to-strong-buy-by-marketsmojo-3600320",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SwedishOrphanBi_mojoScore_3600320.png",
        "date": "2025-10-07 20:16:53",
        "description": "Swedish Orphan Biovitrum AB has recently adjusted its evaluation, reflecting significant changes in its financial metrics and market position. The company reported strong quarterly results, with notable increases in pre-tax and net profits, alongside a solid debt-equity ratio, indicating a robust financial foundation within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 2,
    "sid": "1142775",
    "stock_news_url": "https://www.marketsmojo.com/news/swedish-orphan-biovitrum-ab-1142775"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available